Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roman-Marchant, O.
Right arrow Articles by Vincent, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roman-Marchant, O.
Right arrow Articles by Vincent, J.-L.
(Chest. 2004;126:173-178.)
© 2004 American College of Chest Physicians

Septic Shock of Early or Late Onset*

Does It Matter?

Oscar Roman-Marchant, MD; Carlos E. A. Orellana-Jimenez, MD; Daniel De Backer, MD, PhD; Christian Melot, MD, PhD, MSciBiostat and Jean-Louis Vincent, MD, PhD, FCCP

* From the Department of Intensive Care, Erasme Hospital, Free University of Brussels, Belgium.

Correspondence to: Jean-Louis Vincent, MD, PhD, FCCP, Department of Intensive Care Medicine, Erasme University Hospital, Route de Lennik 808, 1070 Brussels, Belgium; e-mail: jlvincen{at}ulb.ac.be

Study objectives: To determine possible differences in morbidity and mortality between early and late onset of septic shock in ICU patients.

Design: Systematic data collection.

Setting: Thirty-one–bed, mixed, medicosurgical ICU in a university hospital.

Patients: All 65 patients who acquired septic shock after admission to the ICU between February 1999 and April 2000.

Interventions: None.

Measurements and results: Forty-one of the 65 patients presented with septic shock within 24 h of admission to the ICU (early septic shock [ESS]); the other 21 patients acquired septic shock > 24 h after ICU admission (late septic shock [LSS]). Eleven patients had a second episode (7 patients in the ESS group, and 4 patients in the LSS group), and 1 patient in the LSS group had a third episode of septic shock. Patients with ESS had higher APACHE (acute physiology and chronic health evaluation) II (mean ± SD, 26 ± 6 vs 20 ± 6; p = 0.002) and sequential organ failure assessment (SOFA) scores (11 ± 3 vs 7 ± 3, p < 0.001) on ICU admission, and a higher blood lactate concentration at the onset of shock (median 3.70 mEq/L; interquartile range, 2.6 to 6.6 mEq/L; vs median, 2.50 mEq/L [interquartile range, 1.8 to 4.0 mEq/L], p = 0.03) than patients with LSS. However, the duration of septic shock (median, 42 h [interquartile range, 21 to 97 h] vs median, 93 h [interquartile range, 32 to 241 h], p = 0.058) and the length of ICU stay after the onset of septic shock (median, 75 h; [interquartile range, 38 to 203 h] vs median, 321 h [interquartile range, 96 to 438 h], p = 0.018), was shorter in patients with ESS than patients with LSS. The ICU mortality rate was 63% (26 patients) in the ESS group, and 88% (21 patients) in the LSS group (p = 0.071). At the onset of the first episode of shock, patients with ESS had higher SOFA scores (11 ± 3 vs 9 ± 3, p = 0.045), lower pH (7.24 ± 0.15 vs 7.33 ± 0.12, p = 0.01), and were treated with higher doses of dopamine (median, 20 µg/kg/min [interquartile range, 14 to 20 µg/kg/min] vs median, 12 µg/kg/min [interquartile range, 8 to 20 µg/kg/min], p = 0.028) than patients with LSS.

Conclusions: Septic shock is more severe when of early onset, as reflected by more severe organ dysfunction, greater lactic acidosis, and higher vasopressor requirements, yet the outcome is better, as reflected by a shorter duration of the shock episode, shorter ICU stay, and slightly lower mortality rates. These differences may influence clinical trials of therapeutic agents for sepsis, and should be taken into account when analyzing the results.

Key Words: blood lactate • length of stay • organ failure • outcome




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J.-L. Vincent and E. Abraham
The Last 100 Years of Sepsis
Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 256 - 263.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
M. I. Rudis and K. L. Rowland
Current Concepts in Severe Sepsis and Septic Shock
Journal of Pharmacy Practice, October 1, 2005; 18(5): 351 - 362.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.